126 related articles for article (PubMed ID: 29141378)
41. [Cisplatin resistant effects of dihydrofolate reductase gene expression up-regulation in epithelial ovarian cancer].
Li Z; Wang Q; Zhang W; Yang Z; Li L
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):854-60. PubMed ID: 26887775
[TBL] [Abstract][Full Text] [Related]
42. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
43. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
44. [Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro].
Zhang W; Yang YZ; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):528-31. PubMed ID: 24284226
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
46. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
Hu C; Dong T; Li R; Lu J; Wei X; Liu P
Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y
Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135
[TBL] [Abstract][Full Text] [Related]
48. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
[TBL] [Abstract][Full Text] [Related]
49. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells].
Hu XX; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):579-83. PubMed ID: 17181964
[TBL] [Abstract][Full Text] [Related]
50. [Silencing HMGB1 expression by lentivirus-mediated small interfering RNA (siRNA) inhibits the proliferation and invasion of colorectal cancer LoVo cells in vitro and in vivo].
Li Z; Wang H; Song B; Sun Y; Xu Z; Han J
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):664-70. PubMed ID: 26813430
[TBL] [Abstract][Full Text] [Related]
51. Citrate synthase expression affects tumor phenotype and drug resistance in human ovarian carcinoma.
Chen L; Liu T; Zhou J; Wang Y; Wang X; Di W; Zhang S
PLoS One; 2014; 9(12):e115708. PubMed ID: 25545012
[TBL] [Abstract][Full Text] [Related]
52. [Effect of reduced expression of Her2 by RNA interference on the biological characters of ovarian carcinoma cells].
Wang KF; Cui H; Feng J; Yang R; Liang XD; Chang XH; Li Y; Cheng YX; Cheng HY; Ye X
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):622-5. PubMed ID: 19087501
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
Wei C; Zhang X; He S; Liu B; Han H; Sun X
Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
[TBL] [Abstract][Full Text] [Related]
54. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
Xinxin H; Meng Z; Guiyu Z
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
[TBL] [Abstract][Full Text] [Related]
55. Involvement of GRP78 in the Resistance of Ovarian Carcinoma Cells to Paclitaxel.
Zhang LY; Li PL; Xu A; Zhang XC
Asian Pac J Cancer Prev; 2015; 16(8):3517-22. PubMed ID: 25921171
[TBL] [Abstract][Full Text] [Related]
56. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
57. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.
Zuo P; Ma Y; Huang Y; Ye F; Wang P; Wang X; Zhou C; Lu W; Kong B; Xie X
Gynecol Oncol; 2014 Mar; 132(3):745-51. PubMed ID: 24486602
[TBL] [Abstract][Full Text] [Related]
58. Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway.
Ou-Yang J; Huang LH; Sun XX
Gynecol Obstet Invest; 2017; 82(3):230-239. PubMed ID: 27505004
[TBL] [Abstract][Full Text] [Related]
59. Knockdown of astrocyte elevated gene-1 inhibited cell growth and induced apoptosis and suppressed invasion in ovarian cancer cells.
Wang J; Chen X; Tong M
Gene; 2017 Jun; 616():8-15. PubMed ID: 28323000
[TBL] [Abstract][Full Text] [Related]
60. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
